Prestige Brands to Buy Insight Pharmaceuticals for $750 Million

Prestige Brands Holdings Inc. said Friday it has reached a deal to buy Insight Pharmaceuticals Corp. for $750 million in cash.

Leave a Reply

Your email address will not be published. Required fields are marked *